BusinessDiaMedica Announces Positive Results From FDA Meeting on Planned Clinical Trial in Patients with Chronic Kidney DiseaseBy Nasdaq OMXMay 3, 2018, 12:30 PM UTC
BusinessDiaMedica Therapeutics Announces Final Closing of Private PlacementBy Nasdaq OMXMar 29, 2018, 10:08 PM UTC
BusinessDiaMedica Therapeutics Announces Closing of Private PlacementBy Nasdaq OMXMar 20, 2018, 9:40 PM UTC
BusinessDiaMedica Announces First Enrollment in its PHASE 2 “REMEDY” TRIAL for Acute Ischemic StrokeBy Nasdaq OMXFeb 22, 2018, 12:00 PM UTC
